ResearcherCapital Medical UniversityNo recent work listed

Shenming Li

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5042284061. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 2 papers

Papers 2

ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1. Co-author DOI 10.1038/s41389-022-00418-2 ↗
A multi-omics machine learning framework in predicting the recurrence and metastasis of patients with pancreatic adenocarcinoma. Co-author DOI 10.3389/fmicb.2022.1032623 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hua Fan · 2 shared papers, 2022 · strength 0.38
- Paper A multi-omics machine learning framework in predicting the recurrence and metastasis of patients with pancreatic adenoc… DOI 10.3389/fmicb.2022.1032623 ↗
- Paper ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1. DOI 10.1038/s41389-022-00418-2 ↗
Xingmao Zhang · 1 shared paper, 2022 · strength 0.15
- Paper ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1. DOI 10.1038/s41389-022-00418-2 ↗
Chenggang Li · 1 shared paper, 2022 · strength 0.15
- Paper ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1. DOI 10.1038/s41389-022-00418-2 ↗
Zhuo Shao · 1 shared paper, 2022 · strength 0.15
- Paper ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1. DOI 10.1038/s41389-022-00418-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.